Improving access to oncology publications for advocates and people with cancer.

Authors:
Tabernero J; Bowling TE; Rivers J; Chari D; Ghith J and 3 more

Journal:
Cancer

Publication Year: 2022

DOI:
10.1002/cncr.34447

PMCID:
PMC9826100

PMID:
36098654

Journal Information

Full Title: Cancer

Abbreviation: Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST Josep Tabernero has held consultancy or advisory roles for Array Biopharma, AstraZeneca, Avvinity Therapeutics, Bayer, Boehringer Ingelheim, Chugai Pharmaceutical, Daiichi Sankyo, Eli Lilly and Company, EMD Serono, F. Hoffmann‐La Roche Ltd, Genentech Inc., HalioDX SAS, Hutchison MediPharma International, Ikena Oncology, IQVIA, Menarini, Merck Sharp & Dohme, Merus, Mirati Therapeutics, NeoPhore, Novartis, Orion Biotechnology, Peptomyc, Pfizer, Pierre Fabre, Samsung Bioepis, Sanofi, Seattle Genetics, Servier, Taiho Pharmaceutical, Tessa Therapeutics, and TheraMyc; and has participated in educational collaborations with Imedex, Medscape Education, MJH Life Sciences, PeerView Institute for Medical Education, and Physicians Education Resource. Tami Eagle Bowling is a patient ambassador for Pfizer, received an honorarium from Pfizer for her participation as a patient author for this manuscript, and is a volunteer for METAvivor Research and Support. Jamil Rivers received an honorarium from Pfizer for her participation as a patient author for this manuscript, and reports leadership or fiduciary roles with METAvivor Research and Support, Living Beyond Breast Cancer, and The Chrysalis Initiative. Dheepa Chari, Jennifer Ghith, and Roxanne Ferdinand are employees and stockholders of Pfizer Inc. Kelly Shanahan has served as an advisory board member for Pfizer Inc, received an honorarium from Pfizer for her participation as a patient author for this manuscript, received an honorarium for participating in a Medscape virtual event on metastatic breast cancer, and serves as a member of the Board of Directors for METAvivor Research and Support. Neal D. Shore is the Director of Carolina Urologic Research Center, has received payment from Ferring for expert testimony, and has served as a consultant or advisory board member for Abbvie, Amgen, Asieris, Astellas, AstraZeneca, Bayer, BMS, Boston Scientific, Clarity, Clovis Oncology, Cold Genesys, Dendreon, Exact Imaging, Exact Sciences, FerGene, Foundation Medicine, GenesisCare, Invitae, Janssen, Lantheus, Lilly, MDxHealth, Merck, Myovant, Myriad, Nymox, Pacific Edge, Pfizer, Phosphorous, Photocure, PreView, Propella, Sanofi Genzyme, Sema4, Sesen Bio, Specialty Networks, Telix, Tempus, Tolmar, UroGen, and Vaxiion."

Evidence found in paper:

"FUNDING INFORMATION Medical writing support for article development was funded by Pfizer Inc."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025